Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 865-869

  Rozen, Florence ^a   Zhang, Jianchun ^a   Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Insulin like growth factor binding protein 3; Insulin like growth factor I; Insulin like growth factors II; Tumor necrosis factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR IMMUNOLOGY;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; RNA, MESSENGER; THYMIDINE; TRITIUM; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031687589     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N and Williamson B: An endotoxin-induced serum that causes necrosis of tumours. Proc Natl Acad Sci USA 72: 3666-3670, 1975.
2. Old LJ: Tumor necrosis factor (TNF). Science 230: 630-632, 1985.
3. Beutler B and Cerami A: Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584-588, 1986.
4. Sugurman BJ, Aggarwal PE, Hass TE, Figari IS and Paladino MA: Recombinant human tumor necrosis factor: effects on proliferation of normal and transformed cells. Science 230: 943-945, 1985.
5. Jaattela M, Benedict M, Tewari M, Shayman JA and Dixit VM: Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297-2305, 1995.
6. Sgagias MK, Kasid A and Danforth DN Jr: Interleukin-1α and tumor necrosis factor alpha (TNFα) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol Endocrinol 5: 1740-1747, 1991.
7. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, van Arsdell JN, Yamamoto R and Mark DF: Molecular cloning of the complimentary DNA for human tumor necrosis factor. Science 228: 149-154, 1985.
8. Chouaib S, Bertoglio J, Blay JY, Marchiol FC and Fradelizi D: Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and Interleukin-2. Proc Natl Acad Sci USA 85: 6875-6879, 1988.
9. Robinet E, Braunstein GD, Blay JY, Gay F and Chouaib S: Evidence for tumor necrosis factor α involvement in the optimal induction of class-I allospecific cytotoxic T cells. J Immunol 144:4555-4561, 1990.
10. Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R, Hirai M and Tsujimoto M: Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163: 632-643, 1986.
11. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM and Waltersdorph AM: Stimulation of neutrophils by tumor necrosis factor. J Immunol 136:4220-4225, 1986.
12. Scheurich P, Thoma B, Ucer U and Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol 138: 1786-1790, 1987.
13. Philip R and Epstein LB: Tumour necrosis factors as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323: 86-89, 1986.
14. 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci USA 82: 5756-5760, 1985.
15. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D and Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019-1023, 1990.
16. Pusztai L, Clover LM, Cooper K, Starkey PM, Lewis CE and McGee JO: Expression of tumour necrosis factor α and its receptors in carcinoma of the breast. Br J Cancer 70: 280-292, 1994.
17. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55: 249-252, 1995.
18. Clemmons DR: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997.
19. Oh Y, Nagalla S, Yamanaka Y, Kim HS, Wilson E and Rosenfeld RG: Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7. J Biol Chem 271: 30322-30325, 1996.
20. Knauer DJ and Smith GL: Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77: 7252-7256, 1980.
21. Rechter MM: Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what's IGF got to do with it? Endocrinology 138: 2645-2647, 1997.
22. Adamo ML, Shao Z, Lanau F, Chen JC, Clemmons DR, Roberts CT, Le Roith D and Fontana JA: Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1858-1866, 1992.
23. Huynh HT, Yang XF and Pollak M: Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271: 1016-1021, 1996.
24. Rozen F, Yang X, Huynh HT and Pollak M: Antiproliferative action of Vitamin-D-related compounds and insulin-like growth factor binding protein 5 accumulation. J Natl Cancer Inst 89: 652-656, 1997.
25. Nickerson T, Huynh H and Pollak M: Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun 237: 690-693, 1997.
26. Rajah R, Valentinis B and Cohen P: Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272: 12181-12188, 1997.
27. Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin J and Baxter RC: Cloning and expression of the growth hormone-dependent insulin-like growth factorbinding protein. Mol Endocrinol 2: 1176-1185, 1988.
28. Pratt S and Pollak M: Insulin-like growth factor binding protein 3 inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198: 292-297, 1994.
29. Huynh HT, Nickerson T, Pollak M and Yang XF: Regulation of insulin-like growth factor I receptor gene expression by the pure antiestrogen ICI 182,780. Clin Cancer Res 2: 2037-2042, 1996.
30. Pusztai L, Lewis CE and McGee JO: Epidermal growth factor, insulin-like growth factor-1 and basic fibroblast growth factor modulate the cytostatic effect of tumour necrosis factor-alpha on the breast cancer cell line, T47D. Cytokine 5: 169-172, 1993.
31. Conover CA and De Leon DD: Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. J Biol Chem 269:7076-7080, 1994.
32. Danforth DN Jr and Sgagias MK: Tumour necrosis factor-α modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro. J Endocrinol 138: 517-528, 1993.
33. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649, 1995.
34. Oh Y, Mullers HL, Ng L and Rosenfeld RG: Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factorbinding protein-3 action. J Biol Chem 270: 13589-13592, 1995.
35. Wu Y, Tewari M, Cui S and Rubin R: Activation of the insulinlike growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 168: 499-509, 1996.